Medium materiality6/10
UBS Starts Protagonist Therapeutics (PTGX) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS initiates PTGX with Buy; target $184 vs. price $143.73, implying upside ~28%.
- Target $184; price $143.73; upside ~28%.
Key facts
- 01
Target: $184
- 02
Posted price: $143.73
- 03
Analyst firm: UBS
- 04
Analyst: Alice Nettleton
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.